Hybrid Type 2 Effectiveness-Implementation Trial of Status Neutral, Integrated Behavioral Activation and Risk Reduction Intervention for Stimulant Use Among Sexually Active Adolescents and Young Adults (Project IMPACT)

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Maximum Age: 24
Healthy Volunteers: t
View:

• Age 16-24 years, inclusive, at enrollment

• Male or female

• Self-reports condomless anal or vaginal sex while using stimulants (5 hour prior to, or during sex) within the last 4 months; stimulants is defined as crystal methamphetamine, cocaine, and MDMA (e.g., ecstasy, molly)

• Willing and able to provide written informed consent for study participation

• Access to a computer/smartphone/tablet that can use video chat (e.g., Zoom or Google Meet)

• Provide a mailing address where they can receive a package

• Access to stable internet that they can use for more than 2 hours at a time

• Have a private place (where no one else can see or hear) where they can complete visits online

• Reside within the continental U.S.

Locations
United States
California
University of California, Los Angeles
RECRUITING
Los Angeles
Rhode Island
Brown University
RECRUITING
Providence
Contact Information
Primary
Erin Ricketts
erinricketts@westat.com
240-453-2786
Time Frame
Start Date: 2024-10-30
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 360
Treatments
Experimental: IMPACT Group
Participants who report stimulant use in the context of condomless sex will be randomized using a 2:1 allocation ratio with two-thirds being allocated to the IMPACT intervention.
Active_comparator: Enhanced Standard of Care (eSOC) Group
Participants who report stimulant use in the context of condomless sex will be randomized using a 2:1 allocation ratio with one-third being allocated to the eSOC intervention.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Leads: Westat

This content was sourced from clinicaltrials.gov